• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

CMS Grants AABB as an Accrediting Organization for Laboratories Performing HLA Testing

May 23, 2014

Facilities performing human leukocyte antigen (HLA) testing for clinical use must be accredited.  The Centers of Medicare and Medicaid Services (CMS) announced that HLA testing of blood donors for transfusion related acute lung injury (TRALI) risk reduction can be classified as either histocompatibility or general immunology.  This classification allows the AABB to be an accrediting organization.  If there are any questions concerning laboratory accreditation of HLA testing, they should be directed to the AABB accreditation department.

Reference

1. AABB Weekly Report. May 9, 2014.  Vol 20.  No 16.

Filed Under

  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Breast milk-transmission of cytomegalovirus more common than transfusion

  • There’s an App for That: Detecting Anemia Using a Smartphone App

  • Epitope Matched HLA Platelets Are Noninferior to Standard Matched HLA Platelets

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley